Results 261 to 270 of about 91,755 (270)
Some of the next articles are maybe not open access.
Subcutaneous Versus Intravenous Nivolumab for Renal Cell Carcinoma☆
Annals of OncologyJosé M Mota +2 more
exaly
Final, 10-Year Outcomes With Nivolumab Plus Ipilimumab in Advanced Melanoma
New England Journal of MedicineGeorgina V. Long +2 more
exaly

